David Twibell, President of Custom Portfolio Group, was quoted in an article in TheStreet.com November 17: “Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios.” Pharma stocks have bounced back from their prior selloff, but whether they will continue their upward trend under a Donald Trump administration remains unclear.
